Yan Chen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Yan Chen has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Joachim Dieter Mueller
University of Minnesota
8 shared publications Barbara Barylko
UT Southwestern Medical Center, Dallas, Texas
2 shared publications- Iwen F. Grigsby
Institute for Molecular Virology, University of Minnesota, Minneapolis, 18-242 Moos Tower, 515 Delaware St. SE, Minneapolis, MN 55455, USA
2 shared publications Jinhui Li
Department of Physics, University of Minnesota, Minneapolis, Minnesota
2 shared publicationsJoseph P. Albanesi
UT Southwestern Medical Center, Dallas, Texas
2 shared publications- Keir H. Fogarty
Institute for Molecular Virology, University of Minnesota, Minneapolis, 18-242 Moos Tower, 515 Delaware St. SE, Minneapolis, MN 55455, USA
2 shared publications
Latest Publications
- 1 August 2016
- Published by Elsevier in Biophysical Journal
- Vol. 111 (3) , 565-576
Association of Endophilin B1 with Cytoplasmic Vesicles
- 1 August 2016
- Published by Elsevier in Biophysical Journal
- Vol. 111 (3) , 565-576
Association of Endophilin B1 with Cytoplasmic Vesicles
- 1 October 2012
- Published by Elsevier in Biophysical Journal
- Vol. 103 (8) , 1657-1665
Molecular Brightness Analysis Reveals Phosphatidylinositol 4-Kinase IIβ Association with Clathrin-Coated Vesicles in Living Cells
- 1 October 2012
- Published by Elsevier in Biophysical Journal
- Vol. 103 (8) , 1657-1665
Molecular Brightness Analysis Reveals Phosphatidylinositol 4-Kinase IIβ Association with Clathrin-Coated Vesicles in Living Cells
- Open Access
New Insights into HTLV-1 Particle Structure, Assembly, and Gag-Gag Interactions in Living Cells
Human T-cell leukemia virus type 1 (HTLV-1) has a reputation for being extremely difficult to study in cell culture. The challenges in propagating HTLV-1 has prevented a rigorous analysis of how these viruses replicate in cells, including the detailed steps involved in virus assembly. The details for how retrovirus particle assembly occurs are poorly understood, even for other more tractable retroviral systems. Recent studies on HTLV-1 using state-of-the-art cryo-electron microscopy and fluorescence-based biophysical approaches explored questions related to HTLV-1 particle size, Gag stoichiometry in virions, and Gag-Gag interactions in living cells. These results provided new and exciting insights into fundamental aspects of HTLV-1 particle assembly—which are distinct from those of other retroviruses, including HIV-1. The application of these and other novel biophysical approaches promise to provide exciting new insights into HTLV-1 replication.
Open AccessNew Insights into HTLV-1 Particle Structure, Assembly, and Gag-Gag Interactions in Living Cells
Human T-cell leukemia virus type 1 (HTLV-1) has a reputation for being extremely difficult to study in cell culture. The challenges in propagating HTLV-1 has prevented a rigorous analysis of how these viruses replicate in cells, including the detailed steps involved in virus assembly. The details for how retrovirus particle assembly occurs are poorly understood, even for other more tractable retroviral systems. Recent studies on HTLV-1 using state-of-the-art cryo-electron microscopy and fluorescence-based biophysical approaches explored questions related to HTLV-1 particle size, Gag stoichiometry in virions, and Gag-Gag interactions in living cells. These results provided new and exciting insights into fundamental aspects of HTLV-1 particle assembly—which are distinct from those of other retroviruses, including HIV-1. The application of these and other novel biophysical approaches promise to provide exciting new insights into HTLV-1 replication.
- Open Access
- 20 September 2010
- Published by Springer Nature in Retrovirology
- Vol. 7 (1) , 75
Biophysical analysis of HTLV-1 particles reveals novel insights into particle morphology and Gag stoichiometry
Background: Human T-lymphotropic virus type 1 (HTLV-1) is an important human retrovirus that is a cause of adult T-cell leukemia/lymphoma. While an important human pathogen, the details regarding virus replication cycle, including the nature of HTLV-1 particles, remain largely unknown due to the difficulties in propagating the virus in tissue culture. In this study, we created a codon-optimized HTLV-1 Gag fused to an EYFP reporter as a model system to quantitatively analyze HTLV-1 particles released from producer cells. Results: The codon-optimized Gag led to a dramatic and highly robust level of Gag expression as well as virus-like particle (VLP) production. The robust level of particle production overcomes previous technical difficulties with authentic particles and allowed for detailed analysis of particle architecture using two novel methodologies. We quantitatively measured the diameter and morphology of HTLV-1 VLPs in their native, hydrated state using cryo-transmission electron microscopy (cryo-TEM). Furthermore, we were able to determine HTLV-1 Gag stoichiometry as well as particle size with the novel biophysical technique of fluorescence fluctuation spectroscopy (FFS). The average HTLV-1 particle diameter determined by cryo-TEM and FFS was 71 ± 20 nm and 75 ± 4 nm, respectively. These values are significantly smaller than previous estimates made of HTLV-1 particles by negative staining TEM. Furthermore, cryo-TEM reveals that the majority of HTLV-1 VLPs lacks an ordered structure of the Gag lattice, suggesting that the HTLV-1 Gag shell is very likely to be organized differently compared to that observed with HIV-1 Gag in immature particles. This conclusion is supported by our observation that the average copy number of HTLV-1 Gag per particle is estimated to be 510 based on FFS, which is significantly lower than that found for HIV-1 immature virions. Conclusions: In summary, our studies represent the first quantitative biophysical analysis of HTLV-1-like particles and reveal novel insights into particle morphology and Gag stochiometry.
- 20 September 2010
- Published by Springer Nature in Retrovirology
- Vol. 7 (1) , 75
Open AccessBiophysical analysis of HTLV-1 particles reveals novel insights into particle morphology and Gag stoichiometry
Background: Human T-lymphotropic virus type 1 (HTLV-1) is an important human retrovirus that is a cause of adult T-cell leukemia/lymphoma. While an important human pathogen, the details regarding virus replication cycle, including the nature of HTLV-1 particles, remain largely unknown due to the difficulties in propagating the virus in tissue culture. In this study, we created a codon-optimized HTLV-1 Gag fused to an EYFP reporter as a model system to quantitatively analyze HTLV-1 particles released from producer cells. Results: The codon-optimized Gag led to a dramatic and highly robust level of Gag expression as well as virus-like particle (VLP) production. The robust level of particle production overcomes previous technical difficulties with authentic particles and allowed for detailed analysis of particle architecture using two novel methodologies. We quantitatively measured the diameter and morphology of HTLV-1 VLPs in their native, hydrated state using cryo-transmission electron microscopy (cryo-TEM). Furthermore, we were able to determine HTLV-1 Gag stoichiometry as well as particle size with the novel biophysical technique of fluorescence fluctuation spectroscopy (FFS). The average HTLV-1 particle diameter determined by cryo-TEM and FFS was 71 ± 20 nm and 75 ± 4 nm, respectively. These values are significantly smaller than previous estimates made of HTLV-1 particles by negative staining TEM. Furthermore, cryo-TEM reveals that the majority of HTLV-1 VLPs lacks an ordered structure of the Gag lattice, suggesting that the HTLV-1 Gag shell is very likely to be organized differently compared to that observed with HIV-1 Gag in immature particles. This conclusion is supported by our observation that the average copy number of HTLV-1 Gag per particle is estimated to be 510 based on FFS, which is significantly lower than that found for HIV-1 immature virions. Conclusions: In summary, our studies represent the first quantitative biophysical analysis of HTLV-1-like particles and reveal novel insights into particle morphology and Gag stochiometry.
- 1 March 2009
- Published by Elsevier in Biophysical Journal
- Vol. 96 (5) , 1961-1969
Fluorescence Fluctuation Spectroscopy on Viral-Like Particles Reveals Variable Gag Stoichiometry
- 1 March 2009
- Published by Elsevier in Biophysical Journal
- Vol. 96 (5) , 1961-1969
Fluorescence Fluctuation Spectroscopy on Viral-Like Particles Reveals Variable Gag Stoichiometry
- 14 March 2006
- Published by Wiley in Microscopy Research and Technique
- Vol. 69 (3) , 220-226
Probing nucleocytoplasmic transport by two‐photon activation of PA‐GFP
Two‐photon activation of photoactivatable green fluorescent protein (PA‐GFP) provides a unique tool for probing cellular transport processes, because activation is strictly limited to the subfemtoliter optical volume of the two‐photon spot. We demonstrate two‐photon activation of PA‐GFP immobilized in a gel and freely diffusing within cells and recover a quadratic power dependence. Illumination at 820 nm allows simultaneous activation and fluorescence monitoring by two‐photon excitation. Alternatively, we activate PA‐GFP using two‐photon excitation and monitor the fluorescence of the photoconverted product with one‐photon excitation. We probe nucleocytoplasmic transport through the nuclear pore complex of COS‐1 cells, by observing the time‐dependent fluorescence at various locations within the cell after two‐photon activation of PA‐GFP in the nucleus and in the cytoplasm. Two‐photon activation of a tandem construct of two PA‐GFPs showed a markedly slower rate of crossing through the nuclear pore. Analysis based on a restricted diffusion model yields a nuclear pore radius of 4.5 nm, which is in good agreement with previously reported values. This application demonstrates the attractive features of two‐photon photoactivation over traditional techniques, such as photobleaching, for studying transport processes in cells. Microsc. Res. Tech. 69:220–226, 2006.
- 14 March 2006
- Published by Wiley in Microscopy Research and Technique
- Vol. 69 (3) , 220-226
Probing nucleocytoplasmic transport by two‐photon activation of PA‐GFP
Two‐photon activation of photoactivatable green fluorescent protein (PA‐GFP) provides a unique tool for probing cellular transport processes, because activation is strictly limited to the subfemtoliter optical volume of the two‐photon spot. We demonstrate two‐photon activation of PA‐GFP immobilized in a gel and freely diffusing within cells and recover a quadratic power dependence. Illumination at 820 nm allows simultaneous activation and fluorescence monitoring by two‐photon excitation. Alternatively, we activate PA‐GFP using two‐photon excitation and monitor the fluorescence of the photoconverted product with one‐photon excitation. We probe nucleocytoplasmic transport through the nuclear pore complex of COS‐1 cells, by observing the time‐dependent fluorescence at various locations within the cell after two‐photon activation of PA‐GFP in the nucleus and in the cytoplasm. Two‐photon activation of a tandem construct of two PA‐GFPs showed a markedly slower rate of crossing through the nuclear pore. Analysis based on a restricted diffusion model yields a nuclear pore radius of 4.5 nm, which is in good agreement with previously reported values. This application demonstrates the attractive features of two‐photon photoactivation over traditional techniques, such as photobleaching, for studying transport processes in cells. Microsc. Res. Tech. 69:220–226, 2006.
- 1 June 2005
- Published by Elsevier in Biophysical Journal
- Vol. 88 (6) , 4366-4377
Unraveling Protein-Protein Interactions in Living Cells with Fluorescence Fluctuation Brightness Analysis
- 1 June 2005
- Published by Elsevier in Biophysical Journal
- Vol. 88 (6) , 4366-4377
Unraveling Protein-Protein Interactions in Living Cells with Fluorescence Fluctuation Brightness Analysis
- 1 January 2002
- Published by Elsevier in Biophysical Journal
- Vol. 82 (1) , 133-144
Molecular Brightness Characterization of EGFP In Vivo by Fluorescence Fluctuation Spectroscopy
- 1 January 2002
- Published by Elsevier in Biophysical Journal
- Vol. 82 (1) , 133-144
Molecular Brightness Characterization of EGFP In Vivo by Fluorescence Fluctuation Spectroscopy